Price$387.07+3.18 (+0.83%)
2026-06-262026-09-29
News · 26 weeks69-50%
2026-04-052026-09-27
Mix3090d
- Other10(33%)
- Insider7(23%)
- Analyst7(23%)
- SEC Filings4(13%)
- Earnings1(3%)
- Leadership1(3%)
Latest news
25 items- ANALYSTHumana upgraded by Barclays with a new price targetBarclays upgraded Humana from Equal Weight to Overweight and set a new price target of $515.00
- PRNew Humana research finds association between pharmacy care coordination services and improved health outcomes for cancer patientsStudy published in the Expert Review of Pharmacoeconomics & Outcomes Research A new study published in the Expert Review of Pharmacoeconomics & Outcomes Research finds that engagement with a dedicated team of specialty pharmacy care coordinators was associated with improved health outcomes among cancer patients, including fewer hospitalizations and emergency department visits. In tandem, that engagement also was associated with lower medical costs. Titled "The Impact of Clinical Pharmacy Services Within an Oncology Center of Excellence on Patient Outcomes and Cost Efficiency," the study was conducted by Humana Pharmacy Analytics and Consulting. It analyzed health outcomes for people wit
- PRHumana Community Day 2026 Generates 2.2 Million Meals and Community Investments NationwideMore than 18,000 Humana employees joined nonprofit partners across the country to improve community health, demonstrating how a single day of service can create lasting local impact. Humana Inc. (NYSE:HUM) today announced the results of Humana Community Day 2026, the company’s annual nationwide day of service. In its third year, Humana Community Day mobilized more than 18,000 employees across 28 states and Puerto Rico, supported 1,200 nonprofit organizations, and positively impacted 2.25 million lives and community members through volunteer projects focused on food security, neighborhood revitalization, environmental stewardship and social connection. This press release features multimed
- PRNew Study Links Integrated Specialty Pharmacy Care to Faster Access and Lower CostsResearch finds use of a specialty pharmacy connected to Medicare Advantage beneficiaries’ health plans was associated with receiving key medications nearly a week sooner and out-of-pocket cost savings of more than $100. A new peer-reviewed study from Humana Healthcare Research published in Health Affairs Scholar found that Medicare Advantage beneficiaries who used an integrated specialty pharmacy, which coordinates pharmacy services with a beneficiary’s health plan, experienced faster access to specialty medications and lower out-of-pocket pharmacy costs compared with beneficiaries using non-integrated specialty pharmacies. The research suggests that greater coordination between health pl
- INSIDERChief Medical Officer Nundy Shantanu was granted 2,549 units of Humana Common (SEC Form 4)4 - HUMANA INC (0000049071) (Issuer)
- PRHumana Earns 2026 Great Place To Work Certification™ and PEOPLE Companies That Care® RecognitionDesignations reflect Humana’s continued commitment to a caring culture that supports employees, members and communitiesHumana Inc. (NYSE:HUM), one of the nation’s leading consumer healthcare companies, has earned 2026 Great Place To Work Certification™ for the fifth consecutive year and has again been named to the PEOPLE Companies That Care® list. Together, these recognitions reflect Humana’s continued focus on building a workplace where employees feel supported, connected to purpose and empowered to make a meaningful impact.Great Place to Work certification is based on direct employee feedback about workplace culture, trust, and overall experience. In 2026, 79% of Humana employees said the
- PRHumana Board Declares Payment of Quarterly Dividend to StockholdersHumana Inc. (NYSE:HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on November 27, 2026 to stockholders of record as of the close of business on October 30, 2026. About Humana Humana (NYSE:HUM) is a leading U.S. healthcare company. Through our Humana insurance services and our CenterWell healthcare services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare and Medicaid, families, individuals, military service personnel, and communities at la
- PRHumana Foundation Names 2026 Scholarship RecipientsChildren of 18 Louisville-based employees and 80 nationwide awarded scholarships for 2026-27 school year The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE:HUM), today announced 80 winners of college scholarships awarded through the Humana Foundation Scholarship Program. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260901129121/en/Humana employee Brandi Jackson-Hilts with her son Isaiah Hilts Jr., incoming University of Louisiana at Lafayette freshman and one of 80 new scholarship recipients from the Humana Foundation. Scholarships provide up to $3,000 for postsecondary education, including degree, vocational
- SECHumana Inc. filed SEC Form 8-K: Regulation FD Disclosure8-K - HUMANA INC (0000049071) (Filer)
- INSIDERNew insider Nundy Shantanu claimed no ownership of stock in the company (SEC Form 3)3 - HUMANA INC (0000049071) (Issuer)
- PRHumana Names Dr. Shantanu Nundy as Chief Medical OfficerHumana Inc. (NYSE:HUM) today announced that Shantanu Nundy, M.D., will join the company as Chief Medical Officer, effective August 31. A practicing physician, healthcare executive, and technology leader, Dr. Nundy has spent his career using technology to make care better, simpler, and more human. At Humana, he will bring an innovative clinical voice to the enterprise and help shape the design of the company's products, platforms, and use of AI. Dr. Nundy will report to Jim Rechtin, Humana President and CEO, and will serve as a member of the company’s Enterprise Leadership Team. "Clinical excellence is at the heart of Humana’s vision to be a leading consumer healthcare company, and I am th
- PRJames P. Holland to Join Humana as Medicaid PresidentHumana Inc. (NYSE:HUM) today announced that James "J.P." Holland will join the company as senior vice president and President of Medicaid, effective August 17. In this role, Holland will lead the company’s growing Medicaid business, which currently serves more than 1.6 million members in 11 states. Holland will report to Aaron Martin, President of Insurance. "Medicaid is an important part of how we deliver on Humana’s purpose, helping some of the most vulnerable populations access the care and support they need to achieve their best health," said Aaron Martin, President of Insurance at Humana. "J.P. brings deep expertise leading government-sponsored healthcare plans and maintaining strong
- ANALYSTHumana upgraded by Morgan Stanley with a new price targetMorgan Stanley upgraded Humana from Underweight to Equal-Weight and set a new price target of $370.00
- PRHumana Subsidiary iCare Selected for Family Care and Family Care Partnership Contracts Across Southeast WisconsinIndependent Care Health Plan expands service area to all seven counties in Wisconsin's greater southeast region, ensuring continuity for existing members and new access to high-quality long-term care services Independent Care Health Plan (iCare), a Humana subsidiary, has been selected by the Wisconsin Department of Health Services to serve both the Family Care and Family Care Partnership programs in the greater southeast region. This award expands iCare's footprint to all seven counties in the service area and reinforces its leadership in delivering high-quality managed long-term services and supports. The intent to award marks iCare's third consecutive Wisconsin geographic win, with th
- INSIDERDirector Smith Paul John was granted 544 units of Humana Common (SEC Form 4)4 - HUMANA INC (0000049071) (Issuer)
- INSIDERDirector Crawford Frederick John was granted 544 units of Humana Common (SEC Form 4)4 - HUMANA INC (0000049071) (Issuer)
- ANALYSTHumana upgraded by Evercore ISI with a new price targetEvercore ISI upgraded Humana from In-line to Outperform and set a new price target of $480.00
- ANALYSTHumana upgraded by Leerink Partners with a new price targetLeerink Partners upgraded Humana from Market Perform to Outperform and set a new price target of $513.00
- ANALYSTHumana downgraded by Raymond JamesRaymond James downgraded Humana from Outperform to Mkt Perform
- INSIDERNew insider Crawford Frederick John claimed ownership of 21 units of Humana Common (SEC Form 3)3 - HUMANA INC (0000049071) (Issuer)
- INSIDERNew insider Smith Paul John claimed no ownership of stock in the company (SEC Form 3)3 - HUMANA INC (0000049071) (Issuer)
- SECSEC Form 10-Q filed by Humana Inc.10-Q - HUMANA INC (0000049071) (Filer)
- ANALYSTHumana upgraded by BofA Securities with a new price targetBofA Securities upgraded Humana from Neutral to Buy and set a new price target of $500.00
- SECHumana Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - HUMANA INC (0000049071) (Filer)
- PRHumana Elects Paul Smith and Frederick Crawford to Board of DirectorsSmith is the Chief Commercial Officer at Anthropic PBC and brings 30+ years scaling go-to-market strategies at the world's leading enterprise technology companies Crawford brings decades of experience as Chief Financial Officer of three publicly traded insurers, most recently serving as President and Chief Operating Officer of Aflac before his retirement Humana Inc. (NYSE:HUM) today announced that the Company’s Board of Directors has elected Paul Smith and Frederick Crawford as new Board members, effective immediately. Smith is the Chief Commercial Officer at Anthropic, PBC where he leads commercial strategy and global go-to-market operations as the company scales to meet growing e
HUM FAQ
7 questionsWhat does Humana Inc. do?
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured...Where does HUM stock trade?
Humana Inc. (HUM) is listed on NYSE.What sector and industry is HUM in?
Humana Inc. operates in the Health Care sector, Medical Specialities industry.Does HUM pay a dividend?
Yes. HUM's next ex-dividend date is 2026-10-30 with a declared cash dividend of $0.89 per share, payable 2026-11-27.What are analysts saying about HUM?
Humana Inc. has had 8 recent analyst actions on file. The most recent action was from Barclays: Overweight on 2026-09-25.What companies are similar to HUM?
Notable peers in the same industry include UNH (UnitedHealth Group Incorporated), ANTM (Anthem Inc.), ELV (Elevance Health Inc.), CI (The Cigna Group), NTRA (Natera Inc.). Compare HUM side-by-side with any of them on Quantisnow.How can I track HUM on Quantisnow?
Quantisnow aggregates Humana Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow HUM to receive live email and push alerts on every new disclosure.